Back to 
Compagnie Lombard Odier SCmA
Compagnie Lombard Odier SCmA
NTLA
Showing 0 of 20 quarters
Position history for Compagnie Lombard Odier SCmA's holdings in INTELLIA THERAPEUTICS INC
No. Compagnie Lombard Odier SCmA exited its NTLA (Intellia Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 3,000 shares worth $94,860. Compagnie Lombard Odier SCmA already held NTLA in its Q1 2019 13F, the earliest on record, and held it in 19 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.